Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 5 studies | 20% ± 4% | |
enterocyte | 5 studies | 26% ± 4% | |
epithelial cell | 5 studies | 26% ± 6% | |
endothelial cell | 3 studies | 17% ± 2% | |
abnormal cell | 3 studies | 19% ± 4% | |
basal cell | 3 studies | 20% ± 6% | |
ciliated cell | 3 studies | 19% ± 3% | |
retinal cone cell | 3 studies | 25% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9003.60 | 2641 / 2642 | 100% | 120.17 | 702 / 705 |
kidney | 100% | 11147.15 | 89 / 89 | 99% | 188.85 | 892 / 901 |
prostate | 100% | 5333.93 | 245 / 245 | 99% | 47.99 | 496 / 502 |
skin | 98% | 5274.51 | 1771 / 1809 | 99% | 133.30 | 467 / 472 |
esophagus | 100% | 7549.51 | 1440 / 1445 | 90% | 98.71 | 165 / 183 |
uterus | 98% | 3603.96 | 167 / 170 | 90% | 103.78 | 415 / 459 |
intestine | 98% | 10352.89 | 948 / 966 | 84% | 66.87 | 441 / 527 |
bladder | 100% | 6947.71 | 21 / 21 | 80% | 86.60 | 403 / 504 |
adrenal gland | 100% | 9428.41 | 258 / 258 | 72% | 48.59 | 165 / 230 |
breast | 93% | 3690.75 | 426 / 459 | 71% | 31.38 | 797 / 1118 |
stomach | 88% | 4078.81 | 315 / 359 | 72% | 49.75 | 206 / 286 |
ovary | 63% | 1589.74 | 113 / 180 | 69% | 37.57 | 296 / 430 |
lung | 53% | 1007.23 | 305 / 578 | 69% | 101.29 | 802 / 1155 |
pancreas | 32% | 1142.30 | 106 / 328 | 82% | 62.24 | 146 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 165.84 | 80 / 80 |
muscle | 100% | 13829.93 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 97.42 | 1 / 1 |
blood vessel | 99% | 4124.57 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 12079.37 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 164.73 | 43 / 45 |
adipose | 88% | 3997.93 | 1056 / 1204 | 0% | 0 | 0 / 0 |
spleen | 69% | 1822.21 | 166 / 241 | 0% | 0 | 0 / 0 |
thymus | 52% | 944.17 | 341 / 653 | 16% | 17.59 | 94 / 605 |
peripheral blood | 55% | 1634.91 | 508 / 929 | 0% | 0 | 0 / 0 |
liver | 4% | 108.22 | 8 / 226 | 25% | 15.08 | 102 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006865 | Biological process | amino acid transport |
GO_0015881 | Biological process | creatine transmembrane transport |
GO_0006600 | Biological process | creatine metabolic process |
GO_0071705 | Biological process | nitrogen compound transport |
GO_0006936 | Biological process | muscle contraction |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0015812 | Biological process | gamma-aminobutyric acid transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005308 | Molecular function | creatine transmembrane transporter activity |
GO_0005332 | Molecular function | gamma-aminobutyric acid:sodium:chloride symporter activity |
GO_0005309 | Molecular function | creatine:sodium symporter activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | SLC6A8 |
Protein name | Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8) Solute carrier family 6 member 8 Transporter Creatine transporter SLC6A8 variant D Sodium-and chloride-dependent creatine transporter 1 isoform 2 |
Synonyms | |
Description | FUNCTION: Creatine:sodium symporter which mediates the uptake of creatine . Plays an important role in supplying creatine to the brain via the blood-brain barrier (By similarity). . |
Accessions | H7C1I2 ENST00000430077.6 [P48029-4] ENST00000442457.1 H7C0F5 G3FM76 X5DR98 X5D9C4 ENST00000413787.1 ENST00000457723.1 H7C222 ENST00000429147.1 X5D2U0 X5D7P6 A0A023JDV9 P48029 H7C249 ENST00000253122.10 [P48029-1] |